HIGHLIGHTS
- who: Report and colleagues from the Medical Center, Kamogawa City, Department of Metabolism and Endocrinology, Juntendo University, Tokyo have published the research: Review began 08/18/2022 Review ended 10/04/2022 Published 10/06/2022 u00a9 Copyright, in the Journal: (JOURNAL) of November/14,/2020
- what: There are several ways to prevent SGLT2i-related eDKA in the perioperative period.
- future: It is therefore recommended that SGLT2i be discontinued three to four days prior to surgery .
SUMMARY
Prior to her admission, she was on a drug regimen of vildagliptin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.